3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
52
Ovarian Neoplasms
40
Multiple Myeloma
20
Fallopian Tube Neoplasms
13
Lymphoma
12
Sarcoma
11
Carcinoma, Ovarian Epithelial
11
Triple Negative Breast Neoplasms
8
Recurrence
8
Lymphoma, Large B-Cell, Diffuse
8
Neoplasms
7
Lymphoma, Non-Hodgkin
7
Hodgkin Disease
6
Neoplasms, Plasma Cell
5
Sarcoma, Ewing
4
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Lymphoma, Mantle-Cell
4
Burkitt Lymphoma
4
Rhabdomyosarcoma
3
Osteosarcoma
3
Lymphoma, T-Cell, Peripheral
3
Leiomyosarcoma
3
Breast Neoplasms, Male
3
Uterine Cervical Neoplasms
2
Solid Tumors
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pancreatic Neoplasms
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, T-Cell
2
Interventions
fludarabine
2
Paclitaxel
2
Nivolumab
2
Bevacizumab
2
rucaparib
1
liposomal doxorubicin
1
dostarlimab
1
Sunitinib
1
Stem Cell Transplantation
1
Sirolimus
1
Radiotherapy
1
Melphalan
1
Ipilimumab
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Doxorubicin
1
Dexamethasone
1
Celecoxib
1
Carboplatin
1
Capecitabine
1
Busulfan
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Adenocarcinoma, Clear Cell
×
liposomal doxorubicin
×
Clear all
NCT06023862
2026-05-06
DOVE
Yonsei University
Phase 2
Recruiting
198 enrolled